Closed Clinical Trials

The table below contains a list of all ECOG-ACRIN clinical trials that have closed to enrollment since January 1, 2021. Note that this is not a complete listing of all closed trials. On the table below, hover over any of the column headings and click the up/down arrows to sort. You can also search by keyword. To access more information about a particular trial, click on the trial ID, which will link you to more information.

Cancer TypeTarget patient PopulationTrial ID & Link to infoStudy Type ECOG-ACRIN Oversight Committee(s)
AnyWomen with a recent cancer diagnosis E1Q11 / EROS Reproductive Health PlanningCancer Control and Survivorship
AnusMetastatic (advanced)EA2165TreatmentGastrointestinal
BloodAcute promyelocytic leukemia (AML)EA9131TreatmentLeukemia; Cancer Control and Survivorship
Blood Chronic lymphocytic leukemia (CLL)EA9161TreatmentLeukemia
BreastNewly diagnosed, metastatic (advanced)EAI142ImagingBreast
BreastBlack women with breast cancerEAZ171TreatmentBreast; Prevention
BreastTriple negative and basal subtype, including both women and menEA1131TreatmentBreast
KidneyLocalized (no spread) or limited spreadEA8143 / PROSPER RCCTreatmentGenitourinary
Melanoma (Skin)Melanoma, metastatic (advanced), and BRAF V600 typeEA6134 / DREAMseqTreatmentMelanoma
Melanoma (Skin)Cutaneous or unknown primary typeEA6183TreatmentMelanoma
Pancreas or Gastrointestinal TractLocally advanced or metastatic, inoperableEA2142TreatmentGastrointestinal
ProstateMetastatic (advanced), hormone sensitive typeEA8153 / CHAARTED2TreatmentGenitourinary
ECOG-ACRIN Cancer Research Group